MEDVi review
Only one of three lines publishes what the medicine costs; on the other two the figure on the card is the membership and the drug is unpriced.
The verdict
MEDVi publishes $249 a month for injected semaglutide, read August 2026, and that is the only line here carrying a medication price. Its other two show a $99 membership with the drug cost unstated, so this site ranks no figure for either.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- States
- 48
- From
- $249/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 48 states
MEDVi sells injected semaglutide at a flat published rate alongside an oral line and a branded tirzepatide line, both of which advertise a membership rather than a price, with coverage across 48 states.
Who writes the prescription, and what do they see?
The $99 is what the clinical relationship costs on two of the three lines, and the pages state it plainly. What they do not state is what the medication then costs, which leaves the membership priced and the purchase unpriced.
A membership model is legitimate and several sellers here use it well. What separates this one is that the medication figure is absent rather than merely separate, so a buyer pays $99 to discover a number that decides the whole purchase.
What happens when the dose goes up?
The semaglutide line is described as starting at $249 with no intro discount, and nothing published says what that becomes at a higher dose. On the membership lines the dose question cannot even be asked, because no medication figure exists to move.
What the price includes
Six months of injected semaglutide is $1,494 at the published rate. For the other two lines there is nothing to compute: $99 buys access and the drug is billed at a figure the pages describe as varying, with insurance possibly reimbursing some of it. Ask for that number before paying a membership, and treat a refusal as information.
What it claims, and what it cites
The semaglutide line is compounded, prepared to order by a pharmacy the pages do not name, and not reviewed by the FDA before dispensing. A compounded tirzepatide product previously published at $349 no longer appears anywhere on the seller's sites, so this site carries no figure for it rather than repeating a stale one.
Where it holds up, and where it does not
- Strength: One line publishes a flat medication rate
- Strength: The membership amount is stated clearly
- Strength: Coverage across 48 states
- Strength: No intro discount obscures the $249
- Limitation: Two lines publish no medication cost
- Limitation: The membership is paid before the number appears
- Limitation: A previously published line has disappeared
- Limitation: Availability is described as subject to change
What the evidence says about this kind of treatment
The assessment above is about MEDVi. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants the injected semaglutide line, where the figure on the card is the figure for the medicine.
- Wrong for
- A reader considering the oral or branded routes, where nothing published says what the treatment itself costs.
How MEDVi compares
| Seller | Who it suits | Go |
|---|---|---|
| Readers who can pay a year in advance and want the total published rather than implied | See He & She MD → | |
| Readers willing to price the same product twice before buying it once | See Try Ageless → | |
| Readers who want a cheap first month and will ask in writing what follows | See SkinnyRx → |
More GLP-1 telehealth sellers reviews: FoundFridaysGalaGenesis HealthGet Thin MDGlam Health
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Why does this site show no price on two lines?
- Because the $99 on those cards is a membership fee and the medication cost is not stated anywhere, so no total can be built from what is published.
- What does injected semaglutide cost?
- $249 a month, flat and with no introductory discount shown, which makes it the one figure here a reader can plan against.
- What happened to the compounded tirzepatide?
- It is no longer published anywhere on the seller's sites or intake flow, so this site treats it as discontinued rather than carrying an older figure forward.
- Is MEDVi legit?
- MEDVi is a GLP-1 telehealth sellers service. Its stated availability: 48 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is MEDVi expensive compared with other GLP-1 telehealth sellers?
- MEDVi publishes a starting figure of $249/mo. Across the 188 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts MEDVi above the median. The other 12 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.